Published in J Clin Endocrinol Metab on December 01, 1991
Mechanism by which metformin reduces glucose production in type 2 diabetes. Diabetes (2000) 4.80
Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways. J Clin Invest (2001) 3.41
Incretin-based therapies in type 2 diabetes mellitus. J Clin Endocrinol Metab (2008) 1.45
Effects of exenatide plus rosiglitazone on beta-cell function and insulin sensitivity in subjects with type 2 diabetes on metformin. Diabetes Care (2010) 1.33
Effects of metformin on body weight and body composition in obese insulin-resistant children: a randomized clinical trial. Diabetes (2011) 1.32
Treatment of non-alcoholic fatty liver disease. Ther Clin Risk Manag (2007) 1.18
Importance of the intestine as a site of metformin-stimulated glucose utilization. Br J Pharmacol (1994) 0.99
Longer lifespan in male mice treated with a weakly estrogenic agonist, an antioxidant, an α-glucosidase inhibitor or a Nrf2-inducer. Aging Cell (2016) 0.98
A review of thiazolidinediones and metformin in the treatment of type 2 diabetes with focus on cardiovascular complications. Vasc Health Risk Manag (2007) 0.93
B lymphocytes in human subcutaneous adipose crown-like structures. Obesity (Silver Spring) (2012) 0.92
β-cell dysfunction: Its critical role in prevention and management of type 2 diabetes. World J Diabetes (2015) 0.92
The IL-6 Paradox: Context Dependent Interplay of SOCS3 and AMPK. J Diabetes Metab (2013) 0.90
Caloric restriction and chronic inflammatory diseases. Oral Dis (2011) 0.90
Metformin modifies the exercise training effects on risk factors for cardiovascular disease in impaired glucose tolerant adults. Obesity (Silver Spring) (2013) 0.89
Metformin improves glucose effectiveness, not insulin sensitivity: predicting treatment response in women with polycystic ovary syndrome in an open-label, interventional study. J Clin Endocrinol Metab (2014) 0.87
Pharmacotherapy for Nonalcoholic Fatty Liver Disease. Semin Liver Dis (2015) 0.81
Treatment of prediabetes. World J Diabetes (2015) 0.78
Hyperglucagonemia Mitigates the Effect of Metformin on Glucose Production in Prediabetes. Cell Rep (2016) 0.78
Insulin requirement for the antihyperglycaemic effect of metformin. Br J Pharmacol (1994) 0.78
A review of the treatment of type 2 diabetes in children. J Pediatr Pharmacol Ther (2015) 0.77
Advances in diabetes for the millennium: drug therapy of type 2 diabetes. MedGenMed (2004) 0.77
Metformin does not enhance insulin-stimulated vasodilation in skeletal muscle resistance arteries of the OLETF rat. Microcirculation (2013) 0.77
Insulin tolerance test predicts the effectiveness of insulin sensitizers in japanese type 2 diabetic patients. Diabetes Ther (2011) 0.77
Importance of Beta Cell Function for the Treatment of Type 2 Diabetes. J Clin Med (2014) 0.76
Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial. Diabetologia (2015) 0.76
Current and novel therapies for the treatment of nonalcoholic steatohepatitis. Hepatol Int (2007) 0.76
Drugs and insulin resistance: clinical methods of evaluation and new pharmacological approaches to metabolism. Br J Clin Pharmacol (1994) 0.75
Pyruvate Dehydrogenase Phosphatase Regulatory Gene Expression Correlates with Exercise Training Insulin Sensitivity Changes. Med Sci Sports Exerc (2016) 0.75
Clomiphene citrate, metformin or a combination of both as the first line ovulation induction drug for Asian Indian women with polycystic ovarian syndrome: A randomized controlled trial. J Hum Reprod Sci (2016) 0.75
Is It Time to Change the Type 2 Diabetes Treatment Paradigm? Yes! GLP-1 RAs Should Replace Metformin in the Type 2 Diabetes Algorithm. Diabetes Care (2017) 0.75
Lactate Levels with Chronic Metformin Use: A Narrative Review. Clin Drug Investig (2017) 0.75
Assesment of quality-of-life outcomes. N Engl J Med (1996) 8.66
Impaired insulin action in puberty. A contributing factor to poor glycemic control in adolescents with diabetes. N Engl J Med (1986) 3.90
Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians. J Clin Endocrinol Metab (2001) 2.95
A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature (1998) 2.66
Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation (1998) 2.38
Overfeeding rapidly induces leptin and insulin resistance. Diabetes (2001) 2.32
Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. N Engl J Med (1987) 2.30
Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism (1989) 2.27
Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy. Invest Ophthalmol Vis Sci (1996) 2.01
Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes (1988) 1.89
Intracerebroventricular leptin regulates hepatic but not peripheral glucose fluxes. J Biol Chem (1998) 1.80
Effect of sustained physiologic hyperinsulinaemia and hyperglycaemia on insulin secretion and insulin sensitivity in man. Diabetologia (1994) 1.73
Quantitation of hepatic glucose fluxes and pathways of hepatic glycogen synthesis in conscious mice. Am J Physiol (1995) 1.64
Mechanism by which hyperglycemia inhibits hepatic glucose production in conscious rats. Implications for the pathophysiology of fasting hyperglycemia in diabetes. J Clin Invest (1993) 1.61
Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action. J Biol Chem (1997) 1.61
The disposal of an oral glucose load in patients with non-insulin-dependent diabetes. Metabolism (1988) 1.60
Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. Role of substrate availability on estimates of whole body protein synthesis. J Clin Invest (1987) 1.54
In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats. J Clin Invest (1995) 1.52
Increased insulin secretion in puberty: a compensatory response to reductions in insulin sensitivity. J Pediatr (1989) 1.51
Differential gene expression between visceral and subcutaneous fat depots. Horm Metab Res (2003) 1.50
Animal model for maturity-onset diabetes of the young generated by disruption of the mouse glucokinase gene. J Biol Chem (1995) 1.49
Role of the glucosamine pathway in fat-induced insulin resistance. J Clin Invest (1997) 1.49
Hyperglycemia-induced production of acute phase reactants in adipose tissue. J Biol Chem (2001) 1.47
Caloric restriction, body fat and ageing in experimental models. Obes Rev (2004) 1.37
Peripheral but not hepatic insulin resistance in mice with one disrupted allele of the glucose transporter type 4 (GLUT4) gene. J Clin Invest (1997) 1.37
Effect of insulin on oxidative and nonoxidative pathways of free fatty acid metabolism in human obesity. Am J Physiol (1992) 1.25
Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type I diabetes. Ann Intern Med (1985) 1.25
Rate of glucose fall does not affect counterregulatory hormone responses to hypoglycemia in normal and diabetic humans. Diabetes (1987) 1.24
The role of fat cell derived peptides in age-related metabolic alterations. Mech Ageing Dev (2001) 1.15
Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion. N Engl J Med (1988) 1.12
Glycemic control and neuropsychologic function during hypoglycemia in patients with insulin-dependent diabetes mellitus. Ann Intern Med (1990) 1.11
Intermittent hypoglycemia impairs glucose counterregulation. Diabetes (1992) 1.08
Isolation and haracterization nonconverting mutants of bacteriophage epsilon 34. J Bacteriol (1971) 1.07
The tissue concentration of UDP-N-acetylglucosamine modulates the stimulatory effect of insulin on skeletal muscle glucose uptake. J Biol Chem (1997) 1.06
Comparison of thermogenic effect of fructose and glucose in normal humans. Am J Physiol (1986) 1.06
The perception of safe driving ability during hypoglycemia in patients with type 1 diabetes mellitus. Am J Med (1999) 1.05
Abnormal regulation of HGP by hyperglycemia in mice with a disrupted glucokinase allele. Am J Physiol (1997) 1.04
Regional sensitivity and spatial summation in the warmth sense. Physiol Behav (1974) 1.04
Improved insulin sensitivity in patients with type I diabetes mellitus after CSII. Diabetes (1985) 1.02
Effect of sodium intake on insulin sensitivity. Am J Physiol (1993) 1.01
Metabolic effects of sodium metavanadate in humans with insulin-dependent and noninsulin-dependent diabetes mellitus in vivo and in vitro studies. J Clin Endocrinol Metab (1995) 1.01
Valuing quality of life and improvements in glycemic control in people with type 2 diabetes. Diabetes Care (1998) 1.00
Glucose regulates in vivo glucose-6-phosphatase gene expression in the liver of diabetic rats. J Biol Chem (1996) 0.99
Physiological increase in plasma leptin markedly inhibits insulin secretion in vivo. Diabetes (2001) 0.99
Cognitive function in patients with insulin-dependent diabetes mellitus during hyperglycemia and hypoglycemia. Am J Med (1995) 0.99
The effect of leptin on Lep expression is tissue-specific and nutritionally regulated. Nat Med (1999) 0.99
Hepatic overexpression of insulin-like growth factor-II in adulthood increases basal and insulin-stimulated glucose disposal in conscious mice. J Biol Chem (1996) 0.98
Dose-dependent effects of glyburide on insulin secretion and glucose uptake in humans. Diabetes Care (1991) 0.96
Oxidative and non-oxidative glucose metabolism in non-obese type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1988) 0.96
Ability of insulin to modulate hepatic glucose production in aging rats is impaired by fat accumulation. Am J Physiol Endocrinol Metab (2000) 0.94
Effect of beta and alpha adrenergic blockade on glucose-induced thermogenesis in man. J Clin Invest (1984) 0.94
Hepatic and peripheral insulin resistance following streptozotocin-induced insulin deficiency in the dog. Metabolism (1985) 0.94
Induction of hepatic glucose-6-phosphatase gene expression by lipid infusion. Diabetes (1997) 0.93
Free fatty acid and glucose metabolism in human aging: evidence for operation of the Randle cycle. Am J Physiol (1994) 0.93
Aging does not contribute to the decline in insulin action on storage of muscle glycogen in rats. Am J Physiol Regul Integr Comp Physiol (2000) 0.93
Menstrual cyclicity has a profound effect on glucose homeostasis. Fertil Steril (1989) 0.91
Correlation between insulin clearance and insulin responsiveness: studies in normal, obese, hyperthyroid, and Cushing's syndrome patients. Metabolism (1986) 0.91
In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus. Mol Cell Biochem (1996) 0.91
Alterations in glucose metabolism during menstrual cycle in women with IDDM. Diabetes Care (1992) 0.89
Carbon flux via the pentose phosphate pathway regulates the hepatic expression of the glucose-6-phosphatase and phosphoenolpyruvate carboxykinase genes in conscious rats. J Biol Chem (1998) 0.89
Advantages of alpha-glucosidase inhibition as monotherapy in elderly type 2 diabetic patients. J Clin Endocrinol Metab (1998) 0.88
Leucine metabolism in IDDM. Role of insulin and substrate availability. Diabetes (1990) 0.88
Blood glucose awareness training and epinephrine responses to hypoglycemia during intensive treatment in type 1 diabetes. Diabetes Care (1999) 0.88
Exaggerated epinephrine responses to hypoglycemia in normal and insulin-dependent diabetic children. J Pediatr (1987) 0.88
Mechanism of improvement in glucose metabolism after chronic glyburide therapy. Diabetes (1984) 0.87
Hyperglucagonemia and insulin-mediated glucose metabolism. J Clin Invest (1987) 0.86
Measuring quality of life in hypertensive patients with diabetes. Postgrad Med J (1988) 0.85
Sternoclavicular septic arthritis: a novel cause of pleural effusion. Am J Med (1998) 0.85
Blood glucose estimation and symptoms during hyperglycemia and hypoglycemia in patients with insulin-dependent diabetes mellitus. Am J Med (1995) 0.85
Discordant effects of glucosamine on insulin-stimulated glucose metabolism and phosphatidylinositol 3-kinase activity. J Biol Chem (1999) 0.84
Studies on the mass action effect of glucose in NIDDM and IDDM: evidence for glucose resistance. Diabetologia (1997) 0.84
Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals. Diabetes Care (1984) 0.84
Insulin modulates circulating endothelin-1 levels in humans. Metabolism (1993) 0.84
Differential regulation of counterregulatory hormone secretion and symptoms during hypoglycemia in IDDM. Effect of glycemic control. Diabetes Care (1995) 0.83
Hyperglycemia modulates angiotensinogen gene expression. Am J Physiol Regul Integr Comp Physiol (2001) 0.83
Clinical predictors of retinopathy and its progression in patients with type I diabetes during CSII or conventional insulin treatment. Diabetes (1985) 0.82
Non-insulin-dependent diabetes mellitus and elevated serum ferritin level. J Diabetes Complications (1993) 0.82
Primary classic Kaposi's sarcoma of glans penis--appearance on magnetic resonance imaging. Br J Urol (1994) 0.82
Effect of glycemic control on glucose counterregulation during hypoglycemia in NIDDM. Diabetes Care (1998) 0.82
Superior sagittal sinus thrombosis: a rare complication in a child with nephrotic syndrome. Pediatr Radiol (2001) 0.82
Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal. Diabetes (1996) 0.81
Obesity: age-associated weight gain and the development of disease. An interview with Nir Barzilai. Interview by Marc E. Weksler. Geriatrics (1999) 0.80
Stimulus specificity of defects in counterregulatory hormone secretion in insulin-dependent diabetes mellitus: effect of glycemic control. J Clin Endocrinol Metab (1994) 0.80
Immune derangements in asymptomatic male homosexuals in Israel: a pre-AIDS condition? Ann N Y Acad Sci (1984) 0.80
Fat accretion and the regulation of insulin-mediated glycogen synthesis after puberty in rats. Am J Physiol (1997) 0.80
38-Amino acid form of pituitary adenylate cyclase activating peptide induces process outgrowth in human neuroblastoma cells. J Neurosci Res (1993) 0.79
Glucagon increases glutamine uptake without affecting glutamine release in humans. Metabolism (1998) 0.79
Effect of glyburide on glycemic control, insulin requirement, and glucose metabolism in insulin-treated diabetic patients. Diabetes (1987) 0.79
Relation of pressor responsiveness to angiotensin II and insulin resistance in hypertension. J Clin Invest (1994) 0.79
Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response study. Acta Diabetol (1991) 0.79
Insulin effects on glucose and potassium metabolism in vivo: evidence for selective insulin resistance in humans. J Clin Endocrinol Metab (1991) 0.79
Effect of pioglitazone on insulin sensitivity, vascular function and cardiovascular inflammatory markers in insulin-resistant non-diabetic Asian Indians. Diabet Med (2006) 0.79
Is the association between crescentic glomerulonephritis and renal cell carcinoma coincidental? Nephron (1993) 0.78
Quality of life and calcium channel blockade with nifedipine GITS versus amlodipine in hypertensive patients in Spain. Gastrointestinal Therapeutic System. J Hypertens (1998) 0.78
Different effects of glyburide and glipizide on insulin secretion and hepatic glucose production in normal and NIDDM subjects. Diabetes (1987) 0.78
Adrenergic blockade alters glucose kinetics during exercise in insulin-dependent diabetics. J Clin Invest (1984) 0.78
Evidence for a hypothalamic-pituitary versus adrenal cortical effect of glycemic control on counterregulatory hormone responses to hypoglycemia in insulin-dependent diabetes mellitus. J Clin Endocrinol Metab (1996) 0.77
The regulation of body fat distribution and the modulation of insulin action. Int J Obes Relat Metab Disord (2000) 0.77
Food deprivation limits insulin secretory capacity in postpubertal rats. Pediatr Res (2001) 0.77